Draft report SER150 CL-009 was received and will be discussed with the Australian contract organisation and the Serodus biostatistician consultant. In March 2025 the company launched a Private Placement with…

Download investor letter here

Download the minutes here

Serodus AS - Publishes 2024 Annual Report Download it here

Download notice here

Unblinding of the database after SER150 CL-009 was delayed. Calculation of SER150 effect on kidney function compared to placebo is consequently also delayed. Read more here

Contacts to banks for assisting Serodus in selling Serodus AS, the pipeline or the individual assets was initiated. Database for SER150 CL-009 is expected to be unblinded late August or…

Download the minutes here

Read more here

Serodus ASA - Publishes 2023 Annual Report Download it here